Complete Filing Data
Butterfly Network, Inc. reported Stockholders Equity of $195.98 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Butterfly Network, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$77.1M | -$72.5M | -$133.7M | -$168.7M | -$32.4M | -$162.7M | -$99.7M |
| Cost of Revenue * | $51.9M | $33.2M | $49.0M | $33.9M | $45.5M | $107.5M | $48.5M |
| Operating Income Loss | -$86.4M | -$74.4M | -$145.6M | -$193.0M | -$192.7M | -$161.6M | -$102.3M |
| Operating Expenses | $132.1M | $123.2M | $162.5M | $232.5M | $209.8M | $100.4M | $81.4M |
| Income Tax Expense Benefit | $110.0K | -$32.0K | $82.0K | $42.0K | $121.0K | $39.0K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$77.0M | -$72.5M | -$133.6M | -$168.7M | -$32.3M | -$162.7M | -$99.7M |
| Selling And Marketing Expense | $45.9M | $41.6M | $39.1M | $59.5M | $49.6M | $26.3M | $14.3M |
| Revenue From Contract With Customer Excluding Assessed Tax | $97.6M | $82.1M | $65.9M | $73.4M | $62.6M | $46.3M | $27.6M |
| Research And Development Expense | $36.3M | $37.8M | $55.6M | $88.0M | $74.5M | $49.7M | $48.9M |
| Other Nonoperating Income Expense | $2.8M | -$13.0K | -$2.0K | $98.0K | -$2.6M | -$231.0K | -$96.0K |
| Gross Profit | $45.7M | $48.8M | $16.9M | $39.5M | $17.1M | -$61.2M | -$20.9M |
| General And Administrative Expense | $39.2M | $39.8M | $49.6M | $77.6M | $85.7M | $24.4M | $18.2M |
| Interest Expense | $2.0K | $651.0K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$34.0M | -$13.8M | -$14.0M | -$16.9M | -$15.7M | -$21.8M | -$27.4M | -$28.7M | -$33.5M | -$54.7M | -$35.8M | -$44.5M | -$13.6M | -$2.9M | -$690.0K | -$92.2M | -$23.2M | -$24.4M |
| Cost of Revenue * | $25.2M | $8.5M | $7.8M | $8.3M | $8.9M | $7.4M | $6.0M | $7.6M | $6.4M | $8.6M | $8.6M | $7.2M | $19.7M | $8.3M | $6.0M | $79.4M | $11.6M | $9.5M |
| Operating Income Loss | -$35.1M | -$16.1M | -$18.5M | -$17.2M | -$17.2M | -$22.6M | -$32.6M | -$31.3M | -$35.0M | -$46.0M | -$48.5M | -$49.5M | -$57.0M | -$36.7M | -$53.7M | -$91.8M | -$23.1M | -$24.5M |
| Operating Expenses | $31.4M | $31.0M | $31.8M | $29.5M | $29.8M | $32.9M | $41.9M | $42.2M | $44.1M | $57.0M | $59.0M | $57.9M | $51.9M | $44.9M | $60.2M | $22.6M | $23.2M | $23.7M |
| Income Tax Expense Benefit | $16.0K | $20.0K | $7.0K | $58.0K | $17.0K | $3.0K | $2.0K | -$6.0K | $87.0K | $27.0K | $23.0K | $17.0K | -$3.0K | $51.0K | $24.0K | $12.0K | $10.0K | $10.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.0M | -$13.8M | -$14.0M | -$16.9M | -$15.7M | -$21.8M | -$27.4M | -$28.7M | -$33.5M | -$54.7M | -$35.8M | -$44.5M | -$13.6M | -$2.9M | -$666.0K | -$92.2M | -$23.2M | -$24.3M |
| Selling And Marketing Expense | $10.6M | $11.6M | $11.6M | $9.6M | $9.7M | $10.4M | $9.0M | $9.7M | $10.0M | $15.5M | $16.4M | $15.2M | $14.2M | $10.5M | $9.8M | $5.5M | $6.0M | $5.9M |
| Revenue From Contract With Customer Excluding Assessed Tax | $21.5M | $23.4M | $21.2M | $20.6M | $21.5M | $17.7M | $15.4M | $18.5M | $15.5M | $19.6M | $19.2M | $15.6M | $14.6M | $16.5M | $12.4M | $10.1M | $11.8M | $8.7M |
| Research And Development Expense | $8.7M | $8.3M | $9.9M | $8.8M | $9.4M | $10.7M | $12.1M | $15.6M | $16.7M | $22.0M | $23.2M | $23.6M | $21.7M | $17.1M | $15.7M | $12.0M | $11.9M | $12.5M |
| Other Nonoperating Income Expense | -$86.0K | $531.0K | $2.4M | $717.0K | -$59.0K | -$141.0K | -$217.0K | -$60.0K | $17.0K | -$898.0K | -$388.0K | -$100.0K | -$428.0K | -$262.0K | -$631.0K | -$84.0K | -$70.0K | -$29.0K |
| Gross Profit | -$3.8M | $14.9M | $13.4M | $12.2M | $12.6M | $10.3M | $9.4M | $10.9M | $9.1M | $11.0M | $10.6M | $8.3M | -$5.1M | $8.2M | $6.4M | -$69.3M | $165.0K | -$836.0K |
| General And Administrative Expense | $9.3M | $9.1M | $9.6M | $9.4M | $10.1M | $10.4M | $11.6M | $14.7M | $11.0M | $16.6M | $18.7M | $18.8M | $16.0M | $17.3M | $34.6M | $5.1M | $5.3M | $5.2M |
| Interest Expense | $300.0K | $2.0K | $7.0K | $638.0K | $300.0K | $113.0K | $5.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $196.0M | $168.8M | $220.1M | $325.4M | $447.7M | -$361.9M | -$212.3M | -$118.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $154.5M | $92.8M | $138.7M | $166.8M | $426.8M | $60.2M | $90.0M | $214.6M |
| Cash And Cash Equivalents At Carrying Value | $150.5M | $88.8M | $134.4M | $162.6M | $422.8M | $60.2M | $90.0M | |
| Liabilities And Stockholders Equity | $296.5M | $256.1M | $304.3M | $417.6M | $572.0M | $147.2M | ||
| Assets | $296.5M | $256.1M | $304.3M | $417.6M | $572.0M | $147.2M | ||
| Liabilities Current | $65.1M | $48.2M | $44.3M | $51.3M | $49.8M | $69.7M | ||
| Retained Earnings Accumulated Deficit | -$879.2M | -$802.1M | -$729.6M | -$595.9M | -$427.2M | -$394.8M | ||
| Liabilities | $100.6M | $87.3M | $84.2M | $92.2M | $124.3M | $148.2M | ||
| Assets Current | $249.1M | $192.6M | $231.3M | $357.1M | $511.9M | $97.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $61.7M | -$45.9M | -$28.2M | -$260.0M | $366.6M | -$29.8M | -$124.6M | |
| Other Operating Activities Cash Flow Statement | $799.0K | $1.1M | $633.0K | $615.0K | $1.9M | $2.0M | ||
| Prepaid Expense And Other Assets Current | $8.4M | $6.7M | $7.6M | $9.5M | $13.4M | $3.0M | ||
| Property Plant And Equipment Net | $16.6M | $19.5M | $25.3M | $31.3M | $14.7M | $6.9M | ||
| Other Liabilities Noncurrent | $8.3M | $8.6M | $8.9M | $588.0K | $850.0K | $2.1M | ||
| Other Assets Noncurrent | $5.7M | $5.8M | $6.4M | $7.5M | $8.5M | $5.6M | ||
| Inventory Net | $61.4M | $70.8M | $73.0M | $60.0M | $36.2M | $25.8M | ||
| Contract With Customer Liability Noncurrent | $9.4M | $7.3M | $7.4M | $5.0M | $5.5M | $2.8M | ||
| Contract With Customer Liability Current | $26.9M | $16.1M | $15.6M | $15.9M | $13.1M | $8.4M | ||
| Accrued Purchase Commitments Current | $131.0K | $131.0K | $131.0K | $2.1M | $5.3M | $22.9M | ||
| Accrued Liabilities And Other Liabilities | $32.2M | $27.7M | $23.4M | $26.1M | $25.6M | $22.0M | ||
| Accounts Receivable Net Current | $26.7M | $20.8M | $13.4M | $14.7M | $11.9M | $5.8M | ||
| Accounts Payable Current | $5.4M | $4.3M | $5.1M | $7.2M | $5.8M | $16.4M | ||
| Inventory Write Down | $8.0M | $15.0K | $21.1M | $783.0K | $889.0K | $7.1M | $2.7M | |
| Operating Lease Right Of Use Asset | $12.7M | $14.2M | $15.7M | $21.6M | $24.1M | |||
| Operating Lease Liability Noncurrent | $17.7M | $20.4M | $22.8M | $30.0M | $27.7M | |||
| Warrant Liability | $2.7M | $826.0K | $5.4M | $26.2M | ||||
| Assets Held In Trust Noncurrent | $414.3M | |||||||
| Accrued Purchase Commitments Non Current | $14.2M | $19.7M | ||||||
| Temporary Equity Carrying Amount Attributable To Parent | $360.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $203.8M | $232.8M | $239.7M | $181.8M | $194.3M | $204.0M | $257.4M | $277.7M | $296.1M | $343.6M | $386.7M | $412.7M | $451.3M | $446.4M | $436.2M | -$343.9M | -$254.3M | -$233.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $148.2M | $152.2M | $159.2M | $97.8M | $106.1M | $116.8M | $154.3M | $171.2M | $198.4M | $198.0M | $317.7M | $368.7M | $157.3M | $23.6M | $18.9M | $51.7M | $73.4M | $70.0M |
| Cash And Cash Equivalents At Carrying Value | $144.2M | $148.1M | $155.2M | $93.8M | $102.1M | $112.7M | $150.0M | $166.8M | $193.8M | $193.3M | $310.8M | $359.9M | $153.3M | $19.6M | $18.9M | $51.7M | $73.4M | |
| Liabilities And Stockholders Equity | $290.0M | $313.3M | $318.4M | $265.3M | $273.1M | $284.3M | $334.2M | $364.6M | $381.7M | $443.3M | $496.6M | $535.4M | $580.3M | $631.3M | $647.5M | $415.2M | $415.3M | |
| Assets | $290.0M | $313.3M | $318.4M | $265.3M | $273.1M | $284.3M | $334.2M | $364.6M | $381.7M | $443.3M | $496.6M | $535.4M | $580.3M | $631.3M | $647.5M | $415.2M | $415.3M | |
| Liabilities Current | $50.3M | $44.7M | $42.5M | $42.8M | $40.8M | $41.5M | $45.4M | $45.8M | $44.8M | $45.9M | $62.2M | $50.7M | $45.2M | $58.4M | $52.4M | $309.8K | ||
| Retained Earnings Accumulated Deficit | -$863.9M | -$829.9M | -$816.1M | -$784.0M | -$767.1M | -$751.4M | -$685.5M | -$658.1M | -$629.5M | -$562.2M | -$507.5M | -$471.7M | -$412.0M | -$398.4M | -$395.5M | -$391.1K | -$64.1K | |
| Liabilities | $86.2M | $80.5M | $78.7M | $83.4M | $78.8M | $80.3M | $76.8M | $86.9M | $85.5M | $99.6M | $109.9M | $122.8M | $129.1M | $184.9M | $211.3M | $14.8M | $14.6M | |
| Assets Current | $241.4M | $253.7M | $257.4M | $199.5M | $204.5M | $213.3M | $268.6M | $291.8M | $322.5M | $372.5M | $425.5M | $474.3M | $543.5M | $590.7M | $605.2M | $999.7K | $1.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $66.4M | -$21.8M | $31.6M | -$58.2M | -$41.4M | -$20.0M | ||||||||||||
| Other Operating Activities Cash Flow Statement | $56.0K | $244.0K | -$708.0K | $40.0K | $397.0K | $244.0K | ||||||||||||
| Prepaid Expense And Other Assets Current | $7.9M | $7.6M | $7.3M | $7.5M | $7.8M | $8.2M | $8.2M | $10.2M | $12.9M | $14.3M | $19.6M | $23.6M | $16.8M | $9.3M | $9.4M | $240.6K | $340.4K | |
| Property Plant And Equipment Net | $16.8M | $17.3M | $18.0M | $21.2M | $23.0M | $24.4M | $26.4M | $29.2M | $30.4M | $31.4M | $28.6M | $22.8M | $9.4M | $7.4M | $7.3M | |||
| Other Liabilities Noncurrent | $9.5M | $9.5M | $8.9M | $10.9M | $8.6M | $8.2M | $1.3M | $1.4M | $1.4M | $626.0K | $694.0K | $828.0K | $8.0M | $2.3M | $2.1M | |||
| Other Assets Noncurrent | $5.7M | $5.7M | $5.7M | $5.6M | $5.9M | $6.1M | $6.5M | $7.5M | $7.6M | $7.4M | $7.4M | $7.4M | $6.8M | $6.8M | $2.5M | |||
| Inventory Net | $62.2M | $68.9M | $69.3M | $73.3M | $74.2M | $74.5M | $94.0M | $86.8M | $69.4M | $57.7M | $65.6M | $48.4M | $23.8M | $46.9M | $36.1M | |||
| Contract With Customer Liability Noncurrent | $7.9M | $7.2M | $7.6M | $7.0M | $7.4M | $7.2M | $5.3M | $6.0M | $4.3M | $5.6M | $7.0M | $6.3M | $4.9M | $4.8M | $4.0M | |||
| Contract With Customer Liability Current | $16.4M | $15.6M | $15.4M | $16.4M | $14.8M | $14.5M | $15.1M | $13.7M | $14.9M | $13.9M | $15.6M | $13.4M | $12.0M | $10.9M | $9.5M | |||
| Accrued Purchase Commitments Current | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $131.0K | $212.0K | $531.0K | $531.0K | $4.0M | $18.1M | $5.7M | $5.3M | $22.9M | $22.9M | |||
| Accrued Liabilities And Other Liabilities | $29.5M | $24.3M | $22.8M | $22.6M | $21.4M | $21.1M | $21.9M | $23.2M | $23.9M | $25.3M | $25.0M | $28.9M | $22.8M | $19.3M | $14.7M | |||
| Accounts Receivable Net Current | $24.4M | $24.5M | $19.9M | $20.6M | $16.1M | $13.9M | $13.6M | $17.8M | $13.5M | $11.8M | $12.7M | $13.1M | $9.5M | $7.8M | $5.2M | |||
| Accounts Payable Current | $3.3M | $3.3M | $2.3M | $3.7M | $4.5M | $5.8M | $8.1M | $8.4M | $5.4M | $2.7M | $3.5M | $2.7M | $5.0M | $5.3M | $5.3M | |||
| Inventory Write Down | $52.0K | -$81.0K | $600.0K | $6.3M | ||||||||||||||
| Operating Lease Right Of Use Asset | $13.1M | $13.5M | $13.9M | $14.6M | $15.0M | $15.3M | $16.0M | $20.6M | $21.1M | $22.1M | $23.0M | $23.5M | ||||||
| Operating Lease Liability Noncurrent | $18.4M | $19.1M | $19.8M | $21.0M | $21.7M | $22.3M | $23.4M | $28.7M | $29.4M | $30.2M | $30.4M | $30.1M | ||||||
| Warrant Liability | $1.7M | $413.0K | $1.0M | $1.4M | $5.0M | $5.6M | $17.3M | $8.3M | $21.1M | $56.8M | $99.8M | $133.2M | ||||||
| Assets Held In Trust Noncurrent | $414.2M | |||||||||||||||||
| Accrued Purchase Commitments Non Current | $1.4M | $13.8M | $14.2M | $19.7M | $19.7M | |||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $395.4M | $395.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$12.7M | -$41.7M | -$98.8M | -$169.1M | -$189.2M | -$81.7M | -$120.4M |
| Net Cash Provided By Used In Investing Activities | -$3.3M | -$2.7M | $70.4M | -$93.8M | -$9.9M | -$2.4M | -$4.5M |
| Net Cash Provided By Used In Financing Activities | $77.8M | -$1.5M | $228.0K | $2.9M | $565.7M | $54.3M | $324.0K |
| Share Based Compensation | $23.4M | $21.0M | $27.5M | $42.5M | $47.8M | $11.0M | $6.0M |
| Payments To Acquire Property Plant And Equipment | $3.3M | $2.7M | $5.8M | $18.3M | $7.9M | $2.4M | $4.5M |
| Increase Decrease In Vendor Advances | -$3.9M | $2.5M | -$17.1M | -$5.1M | $2.6M | -$1.7M | $48.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.6M | -$1.3M | -$3.0M | -$3.8M | $10.7M | $20.0K | -$931.0K |
| Increase Decrease In Inventories | -$1.4M | -$2.2M | $34.1M | $24.5M | $11.3M | $23.5M | $1.4M |
| Increase Decrease In Deferred Revenue | $12.8M | $435.0K | $2.2M | $2.3M | $7.3M | $7.4M | $3.5M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $5.1M | $3.8M | -$3.6M | $901.0K | $4.0M | $13.1M | $4.4M |
| Increase Decrease In Accounts Receivable | $6.8M | $8.5M | $162.0K | $3.1M | $6.1M | $4.4M | $1.2M |
| Increase Decrease In Accounts Payable Trade | $1.2M | -$841.0K | -$1.9M | $1.2M | -$10.5M | $11.2M | $2.5M |
| Proceeds From Exercise Of Stock Options And Warrants | $816.0K | $64.0K | $228.0K | $3.0M | $21.7M | $2.0M | $324.0K |
| Payments To Acquire Marketable Securities | $0.00 | $0.00 | $297.0K | $75.5M | $1.02B | ||
| Depreciation Depletion And Amortization | $5.9M | $2.1M | $1.3M | $758.0K | |||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $0.00 | $76.5M | $0.00 | $1.02B | ||
| Increase Decrease In Accrued Purchase Commitments | $0.00 | $0.00 | $2.0M | $17.4M | $23.1M | -$42.6M | |
| Increase Decrease In Operating Lease Liability | -$750.0K | -$635.0K | $2.3M | $1.9M | |||
| Proceeds From Equity Infusion From Business Combination Net | $548.4M | -$657.0K | |||||
| Payments Of Debt Issuance Costs | $52.0K | $1.5M | |||||
| Proceeds From Sale Of Property Plant And Equipment | $0.00 | $36.0K | $10.0K | $57.0K | |||
| Proceeds From Issuance Of Common Stock | $81.0M | $0.00 | $0.00 | $25.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$11.7M | -$20.7M | -$43.3M | -$54.2M | -$63.4M | -$19.7M |
| Net Cash Provided By Used In Investing Activities | -$353.0K | -$1.1M | $74.9M | -$4.5M | -$528.2M | -$480.0K |
| Net Cash Provided By Used In Financing Activities | $78.5M | $0.00 | $0.00 | $550.0K | $550.3M | $154.0K |
| Share Based Compensation | $6.3M | $5.5M | $4.2M | $8.7M | $20.3M | $2.7M |
| Payments To Acquire Property Plant And Equipment | $353.0K | $1.1M | $1.3M | $4.5M | $1.3M | $480.0K |
| Increase Decrease In Vendor Advances | -$29.0K | $1.1M | -$2.3M | -$3.4M | $1.7M | -$1.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $570.0K | $376.0K | $3.2M | $5.5M | $6.1M | $1.5M |
| Increase Decrease In Inventories | -$1.4M | $1.4M | $9.4M | $12.1M | $10.3M | -$528.0K |
| Increase Decrease In Deferred Revenue | -$470.0K | -$1.3M | -$1.5M | $1.1M | $2.3M | $1.4M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$5.1M | -$3.3M | -$1.7M | $2.6M | -$3.6M | -$1.5M |
| Increase Decrease In Accounts Receivable | -$857.0K | $751.0K | -$1.1M | $1.2M | -$585.0K | $229.0K |
| Increase Decrease In Accounts Payable Trade | -$2.0M | $703.0K | -$1.6M | -$3.2M | -$11.0M | $1.5M |
| Proceeds From Exercise Of Stock Options And Warrants | $133.0K | $0.00 | $0.00 | $651.0K | $6.3M | |
| Payments To Acquire Marketable Securities | $297.0K | $0.00 | $691.9M | $0.00 | ||
| Depreciation Depletion And Amortization | $2.1M | $839.0K | $458.0K | $285.0K | ||
| Proceeds From Sale And Maturity Of Marketable Securities | $76.5M | $0.00 | $165.0M | $0.00 | ||
| Increase Decrease In Accrued Purchase Commitments | $1.6M | |||||
| Increase Decrease In Operating Lease Liability | -$163.0K | $175.0K | $622.0K | -$306.0K | ||
| Proceeds From Equity Infusion From Business Combination Net | $0.00 | $548.4M | $0.00 | |||
| Payments Of Debt Issuance Costs | $52.0K | $0.00 | ||||
| Proceeds From Sale Of Property Plant And Equipment | $10.0K | |||||
| Proceeds From Issuance Of Common Stock | $81.1M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.31 | -$0.34 | -$0.65 | -$0.84 | -$0.19 | -$26.87 | -$17.08 |
| Weighted Average Number Of Shares Outstanding Basic | 247.1M | 211.7M | 205.4M | 199.8M | 173.8M | 6.1M | 5.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 247.1M | 211.7M | 205.4M | 199.8M | 173.8M | 6.1M | 5.8M |
| Earnings Per Share Basic | $-0.31 | $-0.34 | $-0.65 | $-0.84 | $-0.19 | $-26.87 | $-17.08 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.13 | -$0.06 | -$0.06 | -$0.08 | -$0.07 | -$0.10 | -$0.13 | -$0.14 | -$0.17 | -$0.27 | -$0.18 | -$0.22 | -$0.07 | -$0.02 | -$0.01 | -$15.20 | -$3.85 | -$4.07 |
| Weighted Average Number Of Shares Outstanding Basic | 252.1M | 248.4M | 234.9M | 212.8M | 211.7M | 208.9M | 206.7M | 204.9M | 202.6M | 200.2M | 199.4M | 199.0M | 196.1M | 192.2M | 105.9M | 6.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 252.1M | 248.4M | 234.9M | 212.8M | 211.7M | 208.9M | 206.7M | 204.9M | 202.6M | 200.2M | 199.4M | 199.0M | 196.1M | 192.2M | 105.9M | 6.1M | ||
| Earnings Per Share Basic | $-0.13 | $-0.06 | $-0.06 | $-0.08 | $-0.07 | $-0.10 | $-0.13 | $-0.14 | $-0.17 | $-0.27 | $-0.18 | $-0.22 | $-0.07 | $-0.02 | $-0.01 | $-15.20 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Investment Income Interest | $5.9M | $5.0M | $7.5M | $3.4M | $2.6M | $285.0K | $2.7M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $23.8M | $21.5M | $28.2M | $43.5M | $48.2M | $11.1M | $6.0M |
| Fair Value Adjustment Of Warrants | -$2.3M | $1.9M | -$4.5M | -$20.9M | -$161.1M | ||
| Additional Paid In Capital | $1.08B | $970.9M | $949.7M | $921.3M | $874.9M | $32.9M | |
| Stock Issued During Period Value Stock Options Exercised | $816.0K | $64.0K | $228.0K | $3.0M | $21.7M | $2.0M | $324.0K |
| Vendor Advances Non Current | $5.0M | $15.0M | $15.3M | $12.8M | $37.4M | ||
| Paid In Kind Interest | $1.5M | $1.3M | $0.00 | $0.00 | $389.0K | $1.0M | |
| Other Expenses | $10.8M | $4.1M | $18.2M | $7.3M | |||
| Vendor Advances Current | $27.5M | $2.6M | |||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | -$2.8M | -$738.0K | $1.0K | -$106.0K | |||
| Capital Expenditures Incurred But Not Yet Paid | $396.0K | $470.0K | $9.2M | $4.5M | $1.8M | $564.0K | $75.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $1.4M | $1.5M | $1.7M | $1.2M | $1.3M | $1.5M | $1.9M | $2.0M | $1.8M | $1.3M | $260.0K | $10.0K | $893.0K | $607.0K | $239.0K | $16.0K | $23.0K | $199.0K | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.0M | $6.0M | $6.4M | $4.5M | $6.0M | $5.7M | $7.0M | $10.1M | $4.3M | $9.7M | $9.7M | $8.9M | $10.8M | $7.8M | $20.3M | $2.4M | $2.7M | $2.7M | |
| Fair Value Adjustment Of Warrants | -$207.0K | -$620.0K | -$826.0K | $1.2M | -$620.0K | $207.0K | -$3.5M | -$620.0K | $207.0K | $9.1M | -$12.8M | -$5.2M | -$43.0M | -$33.5M | -$54.1M | $0.00 | |||
| Additional Paid In Capital | $1.07B | $1.06B | $1.06B | $965.8M | $961.4M | $955.4M | $942.9M | $935.8M | $925.6M | $905.9M | $894.2M | $884.3M | $863.2M | $844.8M | $831.6M | $5.4M | $5.1M | ||
| Stock Issued During Period Value Stock Options Exercised | $142.0K | $133.0K | $92.0K | $136.0K | $2.0M | $159.0K | $651.0K | $7.6M | $5.4M | $6.3M | $167.0K | $70.0K | $154.0K | ||||||
| Vendor Advances Non Current | $5.1M | $14.8M | $14.9M | $15.1M | $15.2M | $15.2M | $16.8M | $15.4M | $9.9M | $12.2M | $7.5M | $20.6M | $26.4M | $32.5M | |||||
| Paid In Kind Interest | $346.0K | $299.0K | $0.00 | $389.0K | |||||||||||||||
| Other Expenses | $2.8M | $2.0M | $704.0K | $1.7M | $606.0K | $1.4M | $9.2M | $2.2M | $6.4M | $2.9M | $692.0K | $250.0K | |||||||
| Vendor Advances Current | $2.7M | $10.2M | $32.9M | $35.2M | $20.8M | $16.8M | $29.4M | $25.0M | $17.1M | $9.2M | |||||||||
| Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures | $1.0K | -$2.8M | $1.0K | $1.0K | -$106.0K | ||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid |
Most recent annual filing with the SEC: February 27, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.